Synthesis and anti-tumor activities in human leukemia-derived cells of polyenylpyrroles with a methyl group at the conjugated polyene terminus

[Display omitted] •We synthesized analogs of rumbrin and auxarconjugatin B.•Addition of a methyl group to the conjugated polyene terminus enhances anti-tumor activity.•Certain analogs had potent anti-tumor activity both T-ALL and AML cell lines. To develop novel drugs for treating T-cell acute lymph...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry letters 2023-10, Vol.95, p.129471-129471, Article 129471
Hauptverfasser: Higashi, Tomoya, Yoshida, Chihiro, Hachiro, Yoshifumi, Nakata, Chihiro, Takechi, Azusa, Yagi, Takuya, Miyashita, Kazuya, Kitada, Nobuo, Obata, Rika, Hirano, Takashi, Hara, Takahiko, Maki, Shojiro A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •We synthesized analogs of rumbrin and auxarconjugatin B.•Addition of a methyl group to the conjugated polyene terminus enhances anti-tumor activity.•Certain analogs had potent anti-tumor activity both T-ALL and AML cell lines. To develop novel drugs for treating T-cell acute lymphoblastic leukemia (T-ALL) and acute myeloid leukemia (AML) which are highly malignant hematological tumors, a series of analogs having a polyenylpyrrole structure of natural compounds (rumbrin and auxarconjugatin B) were synthesized and investigated their structure–activity relationships (SAR) of in vitro anti-T-ALL and anti-AML activities. We obtained three findings: (1) introduction of a methyl group at the conjugated polyene terminus enhanced anti-T-ALL activity, (2) analogs with a 3-chloropyrrole moiety had even higher selectivity for T-ALL cells, and (3) some analogs were effective against AML-derived cells. Among the studied compounds, 3-chloro-2-(8-ethoxycarbonylnona-1,3,5,7-tetraenyl) pyrrole 4e was the most promising candidate of T-ALL- and AML-treating drug. This study provides useful structural information for designing novel drugs treating T-ALL and AML.
ISSN:0960-894X
1464-3405
DOI:10.1016/j.bmcl.2023.129471